Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Vertex Pharmaceuticals (Sweden) AB
AB
Active
Org 5569912024
Torsgatan 13, 111 23
Stockholm
Activities of agents involved in the wholesale of other particular products
· NACE 4618
Est. 2014
11 employees
Watchlist
Share
Sweden
/
Companies
/
Activities of agents involved in the wholesale of other particular products
/
Vertex Pharmaceuticals (Sweden) AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
20M
40M
60M
79M
61M
2020
45M
2021
52M
2022
58M
2023
69M
2024
EBITDA
SEK millions
0M
1M
3M
4M
6M
5M
2020
3M
2021
4M
2022
5M
2023
5M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
60 849
45 123
51 614
58 242
68 717
Staff expenses
—
—
—
—
—
EBITDA
5 030
3 424
3 589
4 610
4 985
Depreciation & amort.
−723
−314
−19
−547
−191
EBIT
4 307
3 110
3 570
4 063
4 794
Net financials
—
—
−114
−231
112
Profit before tax
4 307
3 110
3 457
3 832
4 907
Tax
−1 132
−695
−810
−1 008
−1 140
Net profit
3 175
2 415
2 647
2 824
3 767
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
26 771
40 908
65 540
32 610
36 430
Equity
8 474
10 889
13 536
16 360
20 126
Long-term debt
0
0
0
0
0
Short-term debt
18 296
30 019
52 004
16 251
16 304
Total debt
18 296
30 019
52 004
16 251
16 304
Financial ratios
5-year trend
EBITDA margin
7.3%
This company
15.8%
Market median
-54% vs market
2020
2024
Equity ratio
55.2%
This company
38.2%
Market median
+45% vs market
2020
2024
Return on equity
18.7%
This company
18.4%
Market median
+2% vs market
2020
2024
Net profit margin
5.5%
This company
8.1%
Market median
-32% vs market
2020
2024
Asset turnover
1.89×
This company
1.12×
Market median
+69% vs market
2020
2024
Debt / equity
0.81×
This company
0.62×
Market median
+31% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Vertex Pharmaceuticals (Sweden) AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
